2. What type of samples (lungs, livers, urine, culture supernatants, plasma, serum, etc.,) (Mammal = Mice Vs Human) (Plants vs Animals) (microbes = mycobacteria?) (Virus?)
Government's Response: Can be biofluids (plasma, serum, urine) and organs (any organ such as - heart, lung, kidney, jejunum, duodenum, bone marrow, liver etc.). Exact detail of sample will vary from study to study.
3. Lipidomics = Screening/non -targetted/global: What type of lipid class? They are several lipid classes (sphingolipids, ceramides, phospholipids, eicosanoids, fatty acids, and other neutral lipids)
Government's Response: Global and all classes of lipids.
4. MRM = Targetted/Specific: Which lipid classes (as mentioned above)
Government's Response: All classes of lipids
5. Analyses = Upto what stage, Lipid quantities or upto Biostat analyses to compare across various sample types i.e., e.g. diseased vs healthy?
Government's Response: Up to biostat/bioinformatics, correlation with various category of samples, analysis to establish correlation with genders, treatment groups, enough support to make data publishable.
Contractors must provide a statement of acknowledgement of Amendments 0001 and 0002. The response date for offers remains March 27, 2018 by 12:00 p.m. (EST).